Siegfried (SGFEF) Stock Price, News & Analysis

Company Overview

Siegfried Holding AG is a Swiss-based contract development and manufacturing organization (CDMO) specializing in the production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company offers a range of chemical development services, process optimization and scale-up, analytical method development, and regulatory support. Its core expertise encompasses both small-molecule APIs and high-potency compounds, including oncology and other specialty therapies.

In addition to API manufacturing, Siegfried provides end-to-end supply chain services for finished drug products. These services cover solid oral dosage forms, sterile injectables, and complex parenteral preparations. The company works with biotechnology and pharmaceutical clients at all stages—from early-stage clinical supply through commercial launch—ensuring compliance with current Good Manufacturing Practices (cGMP) and international regulatory standards.

Headquartered in Zofingen, Switzerland, Siegfried operates a network of cGMP facilities across Europe and North America, with additional sites in Germany and the United States. This global footprint supports seamless technology transfer and risk-mitigated supply to key markets worldwide. Under the guidance of an experienced leadership team, the company continues to invest in capacity expansion and advanced manufacturing technologies to meet the evolving needs of the biopharma industry.

Key Stats

• Today's Range: $114.35 to $114.35
• 50-Day Range: $102.50 to $114.35
• 52-Week Range: $114.35 to $1,025.00
• Volume: N/A
• Average Volume: 233 shs
• Market Capitalization: N/A
• P/E Ratio: 8.28
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SGFEF Stock Analysis - Frequently Asked Questions

How have SGFEF shares performed this year?

Siegfried's stock was trading at $965.00 at the beginning of 2025. Since then, SGFEF stock has decreased by 88.2% and is now trading at $114.35.

How do I buy shares of Siegfried?

Shares of SGFEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/21/2025
• Next Earnings (Estimated): 8/21/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SGFEF
• CIK: N/A
• Web: www.siegfried.ch
• Phone: 41 62 746 1111
• Fax: N/A
• Employees: 3,819
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 8.28
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A